Live Breaking News & Updates on Bio Developments

Stay updated with breaking news from Bio developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Closed Loop Medicine and Pharmanovia commence study for hypertension drug

Closed Loop Medicine, a techbio company specializing in personalized drug-plus-software therapies, and Pharmanovia, a global pharmaceutical firm known for rejuvenating established medicines, have initiated their OptiZest study. ....

United-kingdom , Hakim-yadi , Serge-engamba , James-burt , Closed-loop-medicine , Software-asa-medical-device , Bio-developments , Markets-amp-regulations , Pipelines , Emerging-markets , Hypertension

Blood test could detect cancer seven years before it develops

Proteins present in the blood may be able to predict a person's risk of developing cancer more than seven years before they are diagnosed with the disease, according to new research. ....

United-kingdom , Iain-foulkes , Ruth-travis , Oxford-population-health , Cancer-research-united , Nature-communications , Cancer-research-united-kingdom , Two-cancer-research-united-kingdom-funded , United-kingdom-biobank , Bio-developments , Pipelines , Emerging-markets

Oxford BioDynamics and Kings College London to advance rheumatoid arthritis treatment

Oxford BioDynamics (OBD) and King’s College London (KCL) have partnered to use OBD’s EpiSwitch technology to identify patients at risk of rheumatoid arthritis (RA) who can benefit from abatacept treatment. ....

United-kingdom , Alexandre-akoulitchev , Professor-andy , Oxford-biodynamics , Andrew-cope , Professor-cope , Bio-developments , Pipelines , Emerging-markets , Rheumatoid-arthritis , Clinical-trial

GLP-1R agonists clinical trial design must be improved to ease concerns

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a lot of attention in the pharma industry and beyond. ....

Costanza-alciati , Bio-developments , Pipelines , Emerging-markets , Glp-1 , Eli-lilly , Novo-nordisk , Obesity , Clinical-trial ,

Adare expands global high potency handling capabilities

Adare Pharma Solutions, a tech driven CDMO specializing in oral dosage forms, has announced expansions of its high potency handling capabilities in the U.S. and Europe. ....

Milan , Lombardia , Italy , Philadelphia , Pennsylvania , United-states , Vandalia , Ohio , Adare-pharma-solutions , Orthodox-street , Tom-sellig